Fullerenes in targeted therapies
    1.
    发明授权
    Fullerenes in targeted therapies 失效
    富勒烯在靶向治疗中

    公开(公告)号:US07758889B1

    公开(公告)日:2010-07-20

    申请号:US10623110

    申请日:2003-07-18

    摘要: Herein we disclose a composition, comprising a Cn-Ab, wherein Cn is a fullerene or nanotube comprising n carbon atoms, and Ab is a moiety comprising an antigen-binding site and is linked to the Cn. The composition can further comprise a therapeutic molecule associated with the Cn-Ab. Also, we disclose a method of treating a disease in a mammal, comprising administering to the mammal an effective amount of the composition.

    摘要翻译: 在本文中,我们公开了包含Cn-Ab的组合物,其中C n是包含n个碳原子的富勒烯或纳米管,Ab是包含抗原结合位点并与Cn连接的部分。 组合物还可以包含与Cn-Ab相关的治疗分子。 此外,我们公开了一种治疗哺乳动物疾病的方法,包括向哺乳动物施用有效量的组合物。